Roche

Graphic showing arrows missing the bullseye on a target
Biotech

How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble

Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies.
James Waldron Jun 13, 2025 8:00am
layoffs cut staff reduction workforce

Genentech lays off 143 workers at South San Francisco campus

Jun 11, 2025 12:25pm
Glowing puzzle piece fitting into puzzle

Vividion secures clinical-stage WRN inhibitor from Roche

Jun 4, 2025 9:21am
Businessman climbing steps to pluck a star from the sky

Roche links BTK drug to low relapse rate across 96-week MS trial

May 30, 2025 5:19am
DNA genome CRISPR gene editing

Roche taps Broad Institute to test SBX sequencing in the clinic

May 23, 2025 10:30am
glue scissors art supplies

Genentech sticks 2nd molecular glue deal with Orionis worth $2B

May 21, 2025 8:30am